Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YC-6 (An Nao San Chuan injection) in acute ischemic stroke – randomized double-blind phase IIb trial
CTR20243958Phase 2Active
- Sponsor
- Guangzhou Cellprotek Pharmaceutical Co., Ltd.
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of androtriol in ischemic stroke, sponsored by Guangzhou Cellprotek Pharmaceutical Co., Ltd.. Started Nov 2024; status: active.
02
Drugs
androtriol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20243958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243958.